Preclinical testing and a proof-of-concept study reveal groundbreaking findings: Nextida GC, a unique collagen peptide composition, significantly lowers glucose spikes by an average of 42% after a meal. Tested on healthy participants and pre-diabetic individuals, a 5 or 10 gram dose taken 30 minutes before eating successfully reduced post-meal blood glucose levels.
Rousselot researchers attribute this effect to Nextida GC’s ability to stimulate the incretin hormone GLP-1, naturally supporting blood sugar balance.
Download the white paper to explore how Nextida GC’s multifaceted approach could transform glucose management strategies. | 
